News and Insights

In this Drug Channels article, Senior Vice President of Business Development and Marketing Stacey Little shared her insights on the criteria life sciences companies can use to select the best e-support services provider for their brand.Drug Channels is one of the industry’s leading publications offering expert insights on pharmaceutical economics...

Assist AssistRx Patient Solutions Division President Jan Nielsen shared her insights on "The Top Five Considerations When Choosing a Patient Solutions Provider" with Drug Channels—one of the industry’s leading publications offering expert insights on pharmaceutical economics and the drug distribution system. Learn more about choosing a patient solutions provider that...

Patient assistance programs (or PAPs) are generally sponsored by pharmaceutical manufacturers to provide free drug or financial assistance to patients who are uninsured or underinsured. Patients who qualify for patient assistance programs can receive medication for little or no cost, helping the most in-need patients gain access to therapy if...

AssistRx President and CEO Jeff Spafford lent his voice to Drug Channels—one of the industry's leading publications offering expert insights on pharmaceutical economics and the drug distribution system—to weigh in on how to combat the gross-to-net squeeze and increased competition with a technology-driven pharmacy platform that removes barriers to access,...

Several studies have found that as a patient’s out-of-pocket cost share rises, primary adherence—or the patient’s first prescription fill and use as prescribed—drops significantly. According to IQVIA Institute for Human Data Science’s “Report: Medicine Spending and Affordability in the United States” released in August 2020, prescription abandonment rates are less...